TotalMarketCap

Telomir Pharmaceuticals

TELONasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$57.482 M

$0.78 -10.83%

Close of 6 Nov 2026

As of 6 Nov 2026, Telomir Pharmaceuticals (TELO) has a market capitalization of $57.5M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$10.4M

Loss-making

Shares outstanding

73,675,706

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #320Oncolytics BiotechONCY$58.6M
  2. #321Gossamer BioGOSS$57.9M
  3. #322Telomir PharmaceuticalsTELO$57.5M
  4. #323XBiotechXBIT$57.0M
  5. #324Nomad Power SolutionsNMAD$56.4M

What if Telomir Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$383,258.95

Per share 491,232× higher

Bitcoin $1.53T

$20,737.47

Per share 26,580× higher

Apple $5.02T

$68,079.19

Per share 87,259× higher

Or at a round number

$100.0M$200.0M$500.0M$1.00B

Where these numbers come from

Share counts and financials for Telomir Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.